March 5, 2012

Radio Health Journal's Reed Pence talks with DSN editor in chief Rob Eder; Walgreens president of pharmacy, health and wellness Kermit Crawford; Express Scripts senior director of public affairs Brian Henry; and former Walgreens pharmacy customer Virginia Greathouse about the causes and impact of the Walgreens-ESI dispute.

January 31, 2012

As of Jan. 1, asthma products like the Primatine Mist inhaler became no longer available at retail — leaving consumers with few asthma-care options in the OTC aisle. Drug Store News recently interviewed King Bio president Frank King, who is introducing a new nonprescription inhaler for asthmatics, formulated with homeopathic ingredients, called AsthmaCare under its Safecare banner of products.

January 18, 2012

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

March 6, 2015

CVS Health's chief medical officer is addressing the National Business Group on Health.

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 5, 2015

CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).

March 5, 2015

Jolen has created a new three-part system to remove unwanted facial hair.

March 5, 2015

Nutramax Labs announced Thursday the results of a National Institutes of Health-funded clinical study carried out at the Fred Hutchinson Cancer Research Center in Seattle.

 

March 5, 2015

Rite Aid sees increase in year-to-date comps as total sales increase 3.7%.

March 4, 2015

DexCom received Food and Drug Administration approval for its Dexcom G4 Platinum Continuous Glucose Monitor System with Share. The Share receiver uses a wireless connection via Bluetooth Low Energy between the patient’s receiver and an app on the patient’s smartphone to relay glucose information to apps on the mobile devices of up to five designated recipients, or “followers.”

 

March 4, 2015

The brand's latest survey was designed to help understand the impact of the common cold and/or flu at the individual level.

 

March 4, 2015

Pharmacy Quality Alliance and AllazoHealth announced the formation of a formal research partnership to study and improve medication adherence metrics.

 

March 3, 2015

Researchers have assessed the relationship between changes in a person’s activation level and changes in health outcomes and cost.

March 3, 2015

Healthcare systems should increasingly focus on digital technology as tech-savvy seniors seek more online options to access healthcare services from their home, according to a recent survey.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

February 27, 2015

ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.

February 27, 2015

J&J formed Johnson & Johnson Health and Wellness Solutions to facilitate the development and implementation of programs that focus on wellness and prevention. 

February 27, 2015

Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends. 

February 27, 2015

Walgreens and Vitamin Angels have generated enough funds to help more than 37.5 million children to date.

 

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

Protein Sciences expanded Flublok distribution through Cardinal, McKesson this week. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration.